Regulation of Microbial and Metabolic Balance in the Gut by B Cells 2309411

Abstract Introduction Mucosal microbes must be tightly regulated to prevent infection by opportunistic pathogens, promote commensal homeostasis and maintain gut health. B cells maintain microbial homeostasis through local production of antibodies. We previously reported that Myosin 18A (Myo18A), an F-actin-binding unconventional myosin, controls antibody-mediated immunity. B cell-conditional Myo18A-deficient (Myo18A BKO) mice have increased mature splenic B cells antibody-secreting cells, elevated serum IgM and IgG antibodies, development of autoantibodies, and greater B cell differentiation to plasma cells. In this study, we tested the hypothesis that Myo18A deficiency regulates gut homeostasis by altering local antibody production and composition of the gut microbiome. Methods We measured fecal IgA and conducted shotgun sequencing on colon-derived fecal samples from control Mb1cre/+ and Myo18A BKO mice followed by meta transcriptomics and metabolic pathway analysis. Results Serum and free fecal IgA were decreased and gut microbial diversity altered in Myo18A BKO mice compared to Mb1cre/+ mice. Deletion of Myo18A was associated with enrichment of Erysipelotrichaceae and a decrease in the abundance of Bifidobacterium pseudolongum. As the former is linked to metabolic disorders and inflammatory diseases, and the latter has beneficial roles in health by suppressing diseases such as non-alcoholic fatty liver disease, our data are consistent with poorer gut health in Myo18A BKO mice. Accordingly, Myo18A BKO mice had enlarged livers and significantly higher liver triglyceride levels compared to Mb1cre/+ mice. Analysis of metabolic pathways revealed perturbation of acetate and adenosine metabolism in the fecal environment of Myo18A BKO mice, which further points to an altered gut barrier and pro-inflammatory environment. Conclusion Taken together, our results suggest that B cell Myo18A maintains gut health by regulating commensal diversity and metabolic balance. Funding Source NIH Topic Categories Mucosal and Regional Immunology (MUC)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1540
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulation of Microbial and Metabolic Balance in the Gut by B Cells 2309411

Tina Nunn, Naseer Sangwan, Neetu Gupta, Emily Huang et al.
The Journal of Immunology
Gut microbiota and health
article

Regulation of Microbial and Metabolic Balance in the Gut by B Cells 2309411

Tina Nunn, Naseer Sangwan, Neetu Gupta, Emily Huang, Louisa Hagen, Laura Nagy, Michelle Raymond
article en

Abstract

Abstract Introduction Mucosal microbes must be tightly regulated to prevent infection by opportunistic pathogens, promote commensal homeostasis and maintain gut health. B cells maintain microbial homeostasis through local production of antibodies. We previously reported that Myosin 18A (Myo18A), an F-actin-binding unconventional myosin, controls antibody-mediated immunity. B cell-conditional Myo18A-deficient (Myo18A BKO) mice have increased mature splenic B cells antibody-secreting cells, elevated serum IgM and IgG antibodies, development of autoantibodies, and greater B cell differentiation to plasma cells. In this study, we tested the hypothesis that Myo18A deficiency regulates gut homeostasis by altering local antibody production and composition of the gut microbiome. Methods We measured fecal IgA and conducted shotgun sequencing on colon-derived fecal samples from control Mb1cre/+ and Myo18A BKO mice followed by meta transcriptomics and metabolic pathway analysis. Results Serum and free fecal IgA were decreased and gut microbial diversity altered in Myo18A BKO mice compared to Mb1cre/+ mice. Deletion of Myo18A was associated with enrichment of Erysipelotrichaceae and a decrease in the abundance of Bifidobacterium pseudolongum. As the former is linked to metabolic disorders and inflammatory diseases, and the latter has beneficial roles in health by suppressing diseases such as non-alcoholic fatty liver disease, our data are consistent with poorer gut health in Myo18A BKO mice. Accordingly, Myo18A BKO mice had enlarged livers and significantly higher liver triglyceride levels compared to Mb1cre/+ mice. Analysis of metabolic pathways revealed perturbation of acetate and adenosine metabolism in the fecal environment of Myo18A BKO mice, which further points to an altered gut barrier and pro-inflammatory environment. Conclusion Taken together, our results suggest that B cell Myo18A maintains gut health by regulating commensal diversity and metabolic balance. Funding Source NIH Topic Categories Mucosal and Regional Immunology (MUC)

The Journal of ImmunologyVol. 215(Supplement_1)
Cleveland Clinic (US)
Openalex Percentile: Top 15%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.